VIRGINIA RETIREMENT SYSTEMS ET AL - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 191 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 3.93 and the average weighting 0.1%.

Quarter-by-quarter ownership
VIRGINIA RETIREMENT SYSTEMS ET AL ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$539,550
-18.9%
21,800
-7.2%
0.01%
-16.7%
Q2 2023$665,520
+117.8%
23,500
+76.7%
0.01%
+100.0%
Q1 2023$305,501
-17.6%
13,300
+0.8%
0.00%
-25.0%
Q4 2022$370,656
-3.6%
13,200
-2.9%
0.00%0.0%
Q3 2022$384,608
-36.2%
13,600
-34.3%
0.00%
-33.3%
Q1 2022$603,000
-31.0%
20,700
-22.2%
0.01%0.0%
Q4 2021$874,000
-38.9%
26,600
-14.2%
0.01%
-60.0%
Q3 2021$1,431,000
-46.5%
31,000
-36.1%
0.02%
-42.3%
Q2 2021$2,673,000
+156.3%
48,500
+140.1%
0.03%
+160.0%
Q1 2021$1,043,000
+19.2%
20,2000.0%0.01%
+11.1%
Q4 2020$875,000
+8.7%
20,200
-12.2%
0.01%0.0%
Q3 2020$805,000
-47.4%
23,000
-19.6%
0.01%
-50.0%
Q2 2020$1,530,000
+45.7%
28,600
-3.4%
0.02%
+28.6%
Q1 2020$1,050,000
+3.2%
29,600
+39.0%
0.01%
+27.3%
Q4 2019$1,017,000
+110.1%
21,300
+119.6%
0.01%
+83.3%
Q2 2019$484,000
+59.7%
9,700
+115.6%
0.01%
+50.0%
Q1 2019$303,0004,5000.00%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
BB BIOTECH AG 2,719,998$155,502,0004.38%
Casdin Capital, LLC 295,000$16,865,0004.11%
Opaleye Management Inc. 130,000$7,432,0002.38%
Opus Point Partners Management, LLC 28,704$1,641,0001.42%
Fernwood Investment Management, LLC 27,550$1,575,0000.84%
Rhenman & Partners Asset Management AB 100,000$5,717,0000.77%
COLUMBIA WANGER ASSET MANAGEMENT LLC 760,116$43,456,0000.65%
Eventide Asset Management 214,000$12,234,0000.64%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 262,984$15,035,0000.59%
CAPITAL GUARDIAN TRUST CO 663,089$37,909,0000.54%
View complete list of AGIOS PHARMACEUTICALS INC shareholders